BRM.MU Bristol-Myers Squibb Company

Other Metals & Mining Munich Exchange
- EUR
Market cap
-
P/E
14.5x
P/B
5.41x
ROE
46.5%
Dividend yield
1.57%
Fundamental score
2.9/5

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BRM.MU undervalued?

Graham number

The Graham number of Bristol-Myers Squibb Company cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bristol-Myers Squibb Company fundamental analysis

14 of 22 checks passed

ROE 2/2

High return on equity (46.5%), above 20%.

ROA 1/1

Return on assets (12.3%) is above the industry median (3.2%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 1/1

Last year's EPS growth (178.6%) is above the industry median (6.0%).

Revenue Growth 1/2

Revenue grew 1.4% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 0/1

Current assets do not cover long-term liabilities.

Debt to Equity 0/2

High debt to equity (178.8%), above 100%.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 9.1x against interest expense, well covered.

PE vs Market 1/1

PE (14.5x) is below the market median (16.6x).

PE vs Industry 1/1

PE (14.5x) is below the industry median (16.6x).

PBV 0/1

Price to book (5.4x) is above the industry median (1.8x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 78.6, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (4.9%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 2/2

Dividends paid without a cut of more than 10% for 10 years.

Dividend Growth 1/1

Dividends paid grew over the past 5 years.

Payout Ratio 1/1

Payout ratio is 71.5%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Bristol-Myers Squibb Company stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bristol-Myers Squibb Company

There is no Profile data available for BRM.MU.

Full company profile